129 related articles for article (PubMed ID: 32870062)
1. Balanced and unbalanced chromosomal translocations in myelodysplastic syndromes: clinical and prognostic significance.
Mohamed S; Latagliata R; Limongi MZ; Nigro S; Sangiorgi E; Nanni M; Piccioni A; Campagna A; Spiriti MAA; Carmosino I; Molica M; Mariggiò E; Rosati S; Colafigli G; Fazio F; Luca ML; Benedittis D; Scalzulli E; Breccia M; Mancini M
Leuk Lymphoma; 2020 Dec; 61(14):3476-3483. PubMed ID: 32870062
[TBL] [Abstract][Full Text] [Related]
2. [Chromosomal Aberrations in Myelodysplastic Syndromes].
Ru X; Zhang LY; Li Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1509-12. PubMed ID: 26524067
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemias: review of 5,654 patients with an evaluable karyotype.
Costa D; Muñoz C; Carrió A; Nomdedeu M; Calvo X; Solé F; Luño E; Cervera J; Vallespí T; Berneaga D; Gómez C; Arias A; Such E; Sanz G; Grau J; Insunza A; Calasanz MJ; Ardañaz MT; Hernández JM; Azaceta G; Álvarez S; Sánchez J; Martín ML; Bargay J; Gómez V; Cervero CJ; Allegue MJ; Collado R; Campo E; Nomdedeu B;
Genes Chromosomes Cancer; 2013 Aug; 52(8):753-63. PubMed ID: 23686965
[TBL] [Abstract][Full Text] [Related]
4. Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome.
Volkert S; Kohlmann A; Schnittger S; Kern W; Haferlach T; Haferlach C
Genes Chromosomes Cancer; 2014 May; 53(5):402-10. PubMed ID: 24493299
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome.
Suh KJ; Cheong JW; Kim I; Kim HJ; Shin DY; Koh Y; Yoon SS; Min YH; Ahn JS; Kim YK; Lee YG; Lee JO; Bang SM; Mun YC; Seong CM; Park Y; Kim BS; Hong J; Park J; Lee JH; Kim SY; Lee HG
PLoS One; 2016; 11(11):e0166245. PubMed ID: 27824923
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of chromosomal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemia patients. A study by the spanish group of myelodysplastic syndromes.
Nomdedeu M; Calvo X; Pereira A; Carrió A; Solé F; Luño E; Cervera J; Vallespí T; Muñoz C; Gómez C; Arias A; Such E; Sanz G; Grau J; Insunza A; Calasanz MJ; Ardanaz MT; Hernández-Rivas JM; Azaceta G; Álvarez S; Sánchez J; Martín ML; Bargay J; Gómez V; Cervero CJ; Allegue MJ; Collado R; Campo E; Esteve J; Nomdedeu B; Costa D;
Genes Chromosomes Cancer; 2016 Apr; 55(4):322-7. PubMed ID: 26690722
[TBL] [Abstract][Full Text] [Related]
7. Myelodysplastic Syndrome with t(1;14),t(1;17),t(1;19) Transforms to AML-M5: A Case Report and Literature Review.
Zhang H; Li G; Chang J; Wang H
Ann Clin Lab Sci; 2020 May; 50(3):401-403. PubMed ID: 32581034
[TBL] [Abstract][Full Text] [Related]
8. 11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop.
Bloomfield CD; Archer KJ; Mrózek K; Lillington DM; Kaneko Y; Head DR; Dal Cin P; Raimondi SC
Genes Chromosomes Cancer; 2002 Apr; 33(4):362-78. PubMed ID: 11921271
[TBL] [Abstract][Full Text] [Related]
9. Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH.
Van Limbergen H; Poppe B; Michaux L; Herens C; Brown J; Noens L; Berneman Z; De Bock R; De Paepe A; Speleman F
Genes Chromosomes Cancer; 2002 Jan; 33(1):60-72. PubMed ID: 11746988
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes.
Solé F; Luño E; Sanzo C; Espinet B; Sanz GF; Cervera J; Calasanz MJ; Cigudosa JC; Millà F; Ribera JM; Bureo E; Marquez ML; Arranz E; Florensa L
Haematologica; 2005 Sep; 90(9):1168-78. PubMed ID: 16154839
[TBL] [Abstract][Full Text] [Related]
11. Complex, not monosomal, karyotype is the cytogenetic marker of poorest prognosis in patients with primary myelodysplastic syndrome.
Valcárcel D; Ademà V; Solé F; Ortega M; Nomdedeu B; Sanz G; Luño E; Cañizo C; de la Serna J; Ardanaz M; Marco V; Collado R; Grau J; Montoro J; Mallo M; Vallespí T
J Clin Oncol; 2013 Mar; 31(7):916-22. PubMed ID: 23319689
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements.
Andersen MK; Johansson B; Larsen SO; Pedersen-Bjergaard J
Haematologica; 1998 Jun; 83(6):483-8. PubMed ID: 9676019
[TBL] [Abstract][Full Text] [Related]
13. Jumping translocations in myelodysplastic syndromes.
Yeung CCS; Deeg HJ; Pritchard C; Wu D; Fang M
Cancer Genet; 2016 Sep; 209(9):395-402. PubMed ID: 27751357
[TBL] [Abstract][Full Text] [Related]
14. Correlation of cytogenetic, molecular cytogenetic, and clinical findings in 59 patients with ANLL or MDS and abnormalities of the short arm of chromosome 12.
Streubel B; Sauerland C; Heil G; Freund M; Bartels H; Lengfelder E; Wandt H; Ludwig WD; Nowotny H; Baldus M; Grothaus-Pinke B; Büchner T; Fonatsch C
Br J Haematol; 1998 Mar; 100(3):521-33. PubMed ID: 9504635
[TBL] [Abstract][Full Text] [Related]
15. Characterization by chromosome painting of balanced and unbalanced X chromosome translocations in myelodysplastic syndromes.
Michaux L; Wlodarska I; Mecucci C; Hernandez JM; Van Orshoven A; Michaux JL; Van den Berghe H
Cancer Genet Cytogenet; 1995 Jul; 82(1):17-22. PubMed ID: 7627929
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of monosomal karyotype (MK) in higher-risk patients with myelodysplastic syndromes treated with 5-Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group.
Papageorgiou SG; Vasilatou D; Kontos CK; Kotsianidis I; Symeonidis A; Galanopoulos AG; Hatzimichael E; Megalakaki A; Poulakidas E; Diamantopoulos P; Vassilakopoulos TP; Zikos P; Papadaki H; Mparmparousi D; Bouronikou E; Panayiotidis P; Viniou NA; Pappa V
Am J Hematol; 2018 Jul; 93(7):895-901. PubMed ID: 29659040
[TBL] [Abstract][Full Text] [Related]
17. Chromosome and molecular abnormalities in myelodysplastic syndromes.
Fenaux P
Int J Hematol; 2001 Jun; 73(4):429-437. PubMed ID: 11503956
[TBL] [Abstract][Full Text] [Related]
18. TP53 mutations are associated with very complex karyotype and suggest poor prognosis in newly diagnosed myelodysplastic syndrome patients with monosomal karyotype.
Ren Y; Wang J; Zhang H; Mei C; Ye L; Luo Y; Zhou X; Zhu S; Jiang L; Wang L; Jin J; Tong H
Asia Pac J Clin Oncol; 2020 Jun; 16(3):172-179. PubMed ID: 32030889
[TBL] [Abstract][Full Text] [Related]
19. Analysis of clinical and molecular features of MDS patients with complex karyotype in China.
Ren Y; Mei C; Ye L; Luo Y; Zhou X; Yang H; Lin P; Xu W; Ma L; Jin J; Tong H
Blood Cells Mol Dis; 2019 Mar; 75():13-19. PubMed ID: 30530101
[TBL] [Abstract][Full Text] [Related]
20. [Multiplex fluorescence in situ hybridization in detecting complex chromosomal aberrations in myelodysplastic syndromes].
Xiao B; Li JY; Pan JL; Ma L; Qiu HR; Wu YF; Xue YQ
Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):513-6. PubMed ID: 16468325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
